AI-driven molecular diversification and ligand-based optimization of macitentan derivatives targeting VEGFR1 and endothelin signaling pathways
Sümeyra Koç Sahin, Nouman Ali · 2026
Read AI-driven molecular diversification and ligand-based optimization of macitentan derivatives targeting VEGFR1 and endothelin signaling pathways by Sümeyra Koç Sahin, Nouman Ali (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352451.txt.
Description
Sümeyra Koç Sahin and Nouman Ali design new drugs for preeclampsia in software in this 2026 study. Preeclampsia is a grave blood pressure illness of pregnancy. It involves an overactive growth-factor receptor and excess endothelin, a vessel-squeezing signal. The blood pressure drug macitentan already blocks endothelin receptors. The authors used AI tools to generate modified versions of it.
Two derivatives stood out. One bound most strongly to the growth-factor receptor, the other to the endothelin receptor. Both beat the parent drug in docking tests. Long molecular dynamics simulations showed the pairings stayed stable. Energy calculations and drug-likeness checks also looked favourable. Nothing here has touched a laboratory bench yet. The value is a shortlist of dual-action candidates, ranked and ready for real synthesis and testing.
Catalog record
| CREATOR | Sümeyra Koç Sahin, Nouman Ali |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117745 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |